Explore News By Topic


The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Darolutamide Challenge Awards

LOS ANGELES, Calif., October 25, 2023 – The Prostate Cancer Foundation (PCF) and Bayer today announced two 2023 Bayer-PCF Darolutamide Challenge Awards totaling $2 million to support clinical investigations on darolutamide in prostate cancer. In 2019, the U.S. Food and Drug Administration approved Bayer’s Nubeqa® (darolutamide), an androgen receptor inhibitor... Read More


Washington Commanders announce month-long programming promoting early detection and celebrating survivors and those currently undergoing treatment as part of NFL’s ‘Crucial Catch’ campaign

LANDOVER, Md., October 4, 2023 – Throughout the month of October, the Washington Commanders will host events dedicated to health equity and promoting early detection best practices as part of the NFL's Annual Crucial Catch initiative. To headline the month, the team will host its Crucial Catch-themed game under the... Read More


The Prostate Cancer Foundation Challenges America To Get Healthy This September

LOS ANGELES, Calif., August 31, 2023 – September is Prostate Cancer Awareness Month and the Prostate Cancer Foundation (PCF) is challenging all Americans to Get Healthy with PCF by joining two Prostate Cancer Awareness Challenges: 108 Miles in September Run/Walk Challenge and 30 Foods in 30 Days Healthy Eating Challenge.... Read More


MLB commemorates Father’s Day in partnership with Prostate Cancer Foundation

For its 27th season, MLB and PCF has teamed up to host the Home Run Challenge. Each home run hit in all games beginning May 20 and leading up to Father’s Day (June 18) have raised money to fight prostate cancer. Fans can still visit pcf.org/homerunchallenge to pledge a donation for... Read More


ZERO Prostate Cancer Taps Breast Cancer Leader and Survivor as Next President and CEO

Washington, D.C., June 8, 2023 - After a nationwide executive search, ZERO Prostate Cancer proudly announces Courtney Bugler, CFRE, as its new President and CEO, effective August 7. Bugler, a trailblazing nonprofit leader with extensive executive experience in national health nonprofits, fundraising, and advocacy, will succeed the current President and... Read More


2023 AACR-Prostate Cancer Foundation Scholar-in-Training Award Recipients

The Prostate Cancer Foundation Scholar-in-Training Awards recognize promising young cancer researchers presenting outstanding proffered papers relating to advanced prostate cancer at the American Association for Cancer Research (AACR) Annual Meeting. The Prostate Cancer Foundation is one of 13 organizations sponsoring this highly competitive awards program in conjunction with the AACR.... Read More


Prostate Cancer Foundation Health Equities Expert Panel to Establish Screening Guidelines for Black Men

Leading organization for prostate cancer research aims to reduce Black disparities through screening, early detection, and disease awareness LOS ANGELES, Calif., January 11, 2023 – In its ongoing work to address health disparities for Black men related to prostate cancer, the Prostate Cancer Foundation (PCF) today announced it is convening... Read More


The Prostate Cancer Foundation and ZERO – The End of Prostate Cancer Announce 2022 Young Investigator Award

LOS ANGELES, Calif., December 14, 2022 – The Prostate Cancer Foundation (PCF) and ZERO today announced the 2022 ZERO-PCF VAlor Young Investigator Award for innovative research into the causes of racial disparities in prostate cancer and potential strategies to reduce them. The $225,000 ZERO-PCF VAlor Young  Investigator Award was awarded... Read More


The Prostate Cancer Foundation Mourns Death of Esteemed Board Member Arthur H. Kern

LOS ANGELES, Calif., December 7, 2022 – With great sadness, the Prostate Cancer Foundation (PCF) today shares the news of the loss of our dear friend and esteemed PCF Board member (Emeritus) Arthur H. Kern, who passed away on November 16, 2022, at the age of 76. Art was incredibly... Read More


The Prostate Cancer Foundation Announces Inaugural $30 Million TACTICAL Awards Program for Innovative Prostate Cancer Research

LOS ANGELES, Calif., December 6, 2022 – The Prostate Cancer Foundation (PCF) today announced four inaugural Class of 2022 TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Award recipients. This $30 million program will support cross-disciplinary pioneering research toward the goal of developing 21st Century therapies for the most life-threatening form... Read More